STAT3 and breast carcinoma: Studies involving breast cancer stem cells revealed that STAT3 binds to and activates hTERT promoter in concert with Cluster of Differentiation 44 (CD44) and NF-κB, and that diminished levels of STAT3 resulted in the downregulation of hTERT expression [149].